FFAR1 and obesity disorder: Considering the great inhibitory effects of DC260126 on Th1, Th2 cytokines and pro-inflammatory cytokines expression in obese asthma, it is of great significance to validate the potential use of GPR40 as anti-obesity-associated asthma drug target.